Anaptysbio (ANAB) Other financing activities (2016 - 2025)

Anaptysbio has reported Other financing activities for 7 years, with the latest figure at -$1.5 million in Q2 2025.

• For the quarter ending Q2 2025, Other financing activities fell 4130.56% year-over-year to -$1.5 million; the trailing twelve-month figure through Sep 2025 stood at $7.4 million (up 7085.44% YoY), and the FY2024 full-year result was $7.5 million, changed N/A from the prior year.
• Other financing activities for Q2 2025 stood at -$1.5 million, down from $1.5 million in the prior quarter.
• The five-year high for Other financing activities was $7.4 million in Q4 2024, with the low at -$1.5 million in Q2 2025.
• Historically, Other financing activities has averaged $750400.0 across 4 years, with a median of $39500.0 in 2023.
• Annual changes were most pronounced in 2023 — Other financing activities soared 2050.0% — and 2025, when it tumbled 4130.56%.
• Anaptysbio's Other financing activities stood at -$290000.0 in 2022, then soared by 85.17% to -$43000.0 in 2023, then surged by 17311.63% to $7.4 million in 2024, then plunged by 119.61% to -$1.5 million in 2025.
• The last three Other financing activities figures came in at -$1.5 million (Q2 2025), $1.5 million (Q1 2025), and $7.4 million (Q4 2024), per Business Quant data.